His primary areas of investigation include Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C and Fibrosis. His studies in Internal medicine integrate themes in fields like Surgery, Ribavirin, Hepatitis C virus, Viral load and Alpha interferon. The study incorporates disciplines such as Biopsy, Liver biopsy and Immunology in addition to Gastroenterology.
His research investigates the connection with Cirrhosis and areas like Liver disease which intersect with concerns in Liver transplantation and Asymptomatic. As part of one scientific family, Thierry Poynard deals mainly with the area of Hepatitis C, narrowing it down to issues related to the Hepatitis, and often Alcoholic hepatitis. His biological study spans a wide range of topics, including Necrosis and Natural history.
Thierry Poynard mainly investigates Internal medicine, Gastroenterology, Cirrhosis, Immunology and FibroTest. The various areas that Thierry Poynard examines in his Internal medicine study include Surgery and Hepatitis C virus. His research in Gastroenterology intersects with topics in Chronic hepatitis, Ribavirin and Biopsy, Pathology.
His Cirrhosis study combines topics in areas such as Liver disease, Hepatocellular carcinoma and Hepatology. His study connects Virology and Immunology. Thierry Poynard combines subjects such as Biomarker, Receiver operating characteristic and Fatty liver with his study of FibroTest.
His primary areas of study are Internal medicine, Gastroenterology, FibroTest, Cirrhosis and Fibrosis. He performs multidisciplinary studies into Internal medicine and In patient in his work. His Gastroenterology research includes themes of Chronic hepatitis, Ribavirin, Hepatitis C, Biopsy and Disease.
In his study, which falls under the umbrella issue of Hepatitis C, Vasculitis is strongly linked to Hepatitis C virus. His research integrates issues of Hepatitis B, Prospective cohort study and Liver stiffness in his study of FibroTest. His biological study spans a wide range of topics, including Surgery, Jaundice, Liver biopsy, Shear wave elastography and Gold standard.
Thierry Poynard spends much of his time researching Internal medicine, Gastroenterology, Cirrhosis, FibroTest and Hepatitis C. Thierry Poynard usually deals with Internal medicine and limits it to topics linked to Hepatitis C virus and Vasculitis. His Gastroenterology research incorporates elements of Biopsy, Liver biopsy, Ribavirin, Boceprevir and Fatty liver.
His Cirrhosis research is multidisciplinary, incorporating perspectives in Surgery and Incidence. His study in FibroTest is interdisciplinary in nature, drawing from both Gold standard, Hepatitis B and Biomarker. His Hepatitis C study typically links adjacent topics like Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An algorithm for the grading of activity in chronic hepatitis C
Pierre Bedossa;Thierry Poynard.
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Thierry Poynard;Pierre Bedossa;Pierre Opolon.
The Lancet (1997)
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
Thierry Poynard;Patrick Marcellin;Samuel S Lee;Christian Niederau.
The Lancet (1998)
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection : a prospective study
Françoise Imbert-Bismut;Vlad Ratziu;Laurence Pieroni;Frederic Charlotte.
The Lancet (2001)
Sampling variability of liver biopsy in nonalcoholic fatty liver disease.
Vlad Ratziu;Frédéric Charlotte;Agnès Heurtier;Sophie Gombert.
Viral hepatitis B
Ching Lung Lai;Vlad Ratziu;Man-Fung Yuen;Thierry Poynard.
The Lancet (2003)
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Y Benhamou;M Bochet;V Di Martino;F Charlotte.
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.
Thierry Poynard;John McHutchison;Michael Manns;Christian Trepo.
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
John G. McHutchison;Michael Manns;Keyur Patel;Thierry Poynard.
Liver fibrosis in overweight patients.
Vlad Ratziu;Philippe Giral;Frederic Charlotte;Eric Bruckert.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: